PPT-Session 1 Decentralized Drug Distribution of Antiretroviral Therapy in the Private Sector:

Learning objectives By the end of this session participants will be able to Explain the rationale for decentralized drug distribution DDD of antiretroviral therapy ART List the various DDD of ART models. C:. What . is the business value for private sector partners. ?. Session Facilitator:. Mr. . Scott . Winn. CEO. Strajillion. 1. 1. Network Management Interoperability Technical Exchange. 2. Breakout Session C: What is the business value for private sector partners?. in Addressing Climate Change. - why, how, what….. . Consultation. Washington, April 2008. - . 2. -. Agenda. Transformation towards climate sensitive / climate resilient economies. Private Sector Financing. Module 10:. Pharmacovigilance. Background – definitions. Timeline of pharmacovigilance for a drug from development (pre-market) to post-marketing use. Burden of adverse drug reactions in children. Number of pharmacoepidemiological safety studies in children (Osokogu et al, 2016). Camille Angle, Meagan Bardan, Hanna Schimjawicz and Sean Tabarah. PHM142 Fall . 2018. Instructor: . Ms. Maya Latif. Coordinator: Dr. J. Henderson. HIV Attachment and Penetration. Wilen, C. B., Tilton, J. C., & Doms, R. W. D. (2012). HIV: Cell binding and entry. . This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. in Scaling-Up Zinc Programs. Serge . Raharison. May 2004. Key reference events. The Public Sector. Governmental implication = LEGITIMACY. Important roles:. Policy setting. Regulation and coordination. ACTIVITY CODE . TD342. Antiretroviral Medications: . What . you need to know. Jason J. Schafer, PharmD, MPH, BCPS, AAHIVP. Associate Professor, Department of Pharmacy Practice. Joseph J. Eron, Jr, MD Professor of Medicine and Epidemiology The University of North Carolina at Chapel Hill Chapel Hill, North Carolina Future Directions: Investigational Approaches to Antiretroviral Therapy Recording and Reporting Service Delivery Data. Learning objectives. By the end of this session, participants will be able to:. Describe the information that needs to be collected and reported . Explain how and when to report the data. The University of North Carolina at Chapel Hill. Chapel Hill, North Carolina. Future Directions: Investigational Approaches to Antiretroviral Therapy. Washington, DC: . August . 24, . 2016. . Future Directions: . Learning objectives. By the end of this session, participants will be able to:. Discuss how to create demand for private sector DDD of ART . Identify clients who qualify for DDD enrollment. Describe the process for enrolling clients into DDD of ART. elderly. . individuals. . living. . with. HIV. Catia Marzolini. University Hospital & University of Basel. University of Liverpool. . Disclosures. Research Grant: Gilead. Speaker: . MSD, Gilead. A5173 Study. Intensive . Enfuvirtide. -containing Antiretroviral Therapy . A5173: . Study Design. Source: Gandhi RT, et al. . J . Infect. . Dis. . . 2010;201(2. ):293-6.. Enfuvirtide. +. TDF + (FTC or 3TC) +. With Emergence of Comorbidities. Roger J. . Bedimo. , MD. Professor of Medicine. University of Texas Southwestern Medical Center. Dallas, TX. Learning Objectives. On completion of this presentation, learners will be able to:.